Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
A study to compare the efficacy of an intradermal and an intramuscular single-visit dosing regimen of the rabies vaccine in adults Ended

2024-511506-22-00 Rabies 5 2023-01-11
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 1) Ended

2023-504239-41-00 Hepatitis B, Chronic 5 2023-01-09
Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID… Ended

2024-516463-84-00 Inflammatory cardiovascular involvement due to COVID-19 5 2022-12-13
A randomized first-in-human, Phase 1, single-center, observer-blind, active-controlled 3-arm study to evaluate the safety, tolerability, and… Ended

2022-500681-98-00 Influenza 1 2022-09-14
A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influe… Ended

2022-500657-17-00 Prevention of influenza infection in older adults 6 2022-09-10
Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir A… Ended

2024-511951-16-00 HIV 6 2022-08-30
A 4-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 m… Ended

2022-500244-37-00 COVID-19 4 2022-08-25
Efficacy and Safety of AXL-Inhibitor bemcentinib for the Treatment of Moderate COVID-19 (AXL-SolidAct) Ended

2022-500363-12-00 SARS CoV-2 (COVID-19) 4 2022-08-24
Effective treatment of Hepatitis B with specific immune antibodies Ended

2024-513792-41-00 Chronic hepatitis B 4 2022-08-15
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections … Ended

2023-510088-37-00 Acyclovir-resistant mucocutaneous HSV infections in imm 5 2022-03-15
Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended

2023-508820-37-00 Cytomegalovirus Infection (CMV) 5 2022-02-03
COVID-19 vaccine immunology Ended

2024-517357-27-00 COVID-19 infection 6 2021-12-07
Palivizumab-Controlled Evaluation of Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe … Ended

2022-500752-39-00 Prevention of Respiratory syncytial virus (RSV) infecti 5 2021-11-25
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
Dose Ranging, Switch Study of ISL and MK‑8507 Once-Weekly Ended

2024-511041-19-00 HIV-1 Infection 4 2021-04-06
An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outc… Ended

2024-510663-34-00 Influenza, Human 4 2021-01-29
A Clinical Study to Investigate the Efficacy and Safety of JNJ-73763989 + Nucleos(t)ide Analog in Participants Co-infected with Hepatitis B … Ended

2023-506763-33-00 Hepatitis B and Hepatitis D Viral Co-infection 4 2020-12-18
Virological and immunological assessment in HIV positive participants on 2DR versus 3DR in a prospective randomized controlled switch trial. Ended

2024-515265-34-00 human immunodeficiency viruses (HIV) 6 2020-05-26
The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 Patients who present late on during their acquisition o 5 2019-08-05
Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months Ended

2024-515985-16-00 Herpes Simplex Virus Encephalitis 5 2019-04-25
A study on the safety, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide against chronic Hepati… Ended

2024-512352-38-00 Hepatitis B, Chronic 4 2019-03-28